Improving genomic research through advanced sequencing technologies
Epigenomics Core
['FUNDING_OTHER'] · OKLAHOMA MEDICAL RESEARCH FOUNDATION · NIH-11019320
This study is working to improve how we understand genes and their functions by using advanced technology to look at how DNA works, which could eventually help in finding better treatments for genetic conditions that affect patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OKLAHOMA MEDICAL RESEARCH FOUNDATION (nih funded) |
| Locations | 1 site (OKLAHOMA CITY, UNITED STATES) |
| Trial ID | NIH-11019320 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing genomic regulation studies by upgrading sequencing capabilities at the Oklahoma Medical Research Foundation. It aims to provide advanced services such as chromatin accessibility analysis and DNA-binding protein localization, which are crucial for understanding genetic regulation. By employing experienced personnel and utilizing next-generation sequencing technologies, the project will support various research initiatives, including those related to immunity and cellular processes. Patients may benefit indirectly as the findings could lead to better understanding and treatment of genetic conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with genetic disorders or those involved in studies related to immunity and cellular function.
Not a fit: Patients with conditions unrelated to genetic regulation or those not involved in relevant research areas may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in understanding genetic regulation, potentially improving treatment options for various conditions.
How similar studies have performed: Other research has shown success with similar advanced sequencing approaches, indicating a promising potential for breakthroughs in genomic studies.
Where this research is happening
OKLAHOMA CITY, UNITED STATES
- OKLAHOMA MEDICAL RESEARCH FOUNDATION — OKLAHOMA CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WILEY, GRAHAM — OKLAHOMA MEDICAL RESEARCH FOUNDATION
- Study coordinator: WILEY, GRAHAM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.